GAIN for loss: adalimumab for infliximab-refractory Crohn disease
- PMID: 17577009
- DOI: 10.7326/0003-4819-146-12-200706190-00011
GAIN for loss: adalimumab for infliximab-refractory Crohn disease
Comment on
-
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.Ann Intern Med. 2007 Jun 19;146(12):829-38. doi: 10.7326/0003-4819-146-12-200706190-00159. Epub 2007 Apr 30. Ann Intern Med. 2007. PMID: 17470824 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical